Cargando…

Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells

A pH-triggered mesoporous silica nanoparticle (MSN)-based nano-vehicle for the dual delivery of doxorubicin (DOX)/camptothecin-PEG (CPT-PEG) has been prepared. To enhance its selectivity, the nanoparticles were decorated with glycyrrhetinic acid (GA) to target HepG2 cells. The highly insoluble CPT w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Edo, Gabriel, Fornaguera, Cristina, Borrós, Salvador, Sánchez-García, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694026/ https://www.ncbi.nlm.nih.gov/pubmed/33147860 http://dx.doi.org/10.3390/pharmaceutics12111048

Ejemplares similares

Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery
por: Llinàs, Maria C., et al.
Publicado: (2018)

Isothiocyanate-Functionalized Mesoporous Silica Nanoparticles as Building Blocks for the Design of Nanovehicles with Optimized Drug Release Profile
por: Martínez-Edo, Gabriel, et al.
Publicado: (2019)

LRRK2 Regulates CPT1A to Promote β-Oxidation in HepG2 Cells
por: Lin, Chiao-Wei, et al.
Publicado: (2020)

Quantitative Determination of 18-β-Glycyrrhetinic Acid in HepG2 Cell Line by High Performance Liquid Chromatography Method
por: Nocca, Giuseppina, et al.
Publicado: (2018)

Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier
por: Lv, Yongjiu, et al.
Publicado: (2017)

Enzyme and Thermo Dual-stimuli Responsive DOX Carrier Based on PNIPAM Conjugated Mesoporous Silica
por: Ebrahimi, Seyyed Mostafa, et al.
Publicado: (2022)

The Protective Effects of Isoliquiritigenin and Glycyrrhetinic Acid against Triptolide-Induced Oxidative Stress in HepG2 Cells Involve Nrf2 Activation
por: Cao, Ling-Juan, et al.
Publicado: (2016)

Controlled Release of 18-β-Glycyrrhetinic Acid from Core-Shell Nanoparticles: Effects on Cytotoxicity and Intracellular Concentration in HepG2 Cell Line
por: Nocca, Giuseppina, et al.
Publicado: (2021)

Bi-Functionalized Transferrin@MoS(2)-PEG Nanosheets for Improving Cellular Uptake in HepG2 Cells
por: Xu, Si, et al.
Publicado: (2023)

In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells
por: Lu, Xun, et al.
Publicado: (2011)

Global Proteomics to Study Silica Nanoparticle-Induced Cytotoxicity and Its Mechanisms in HepG2 Cells
por: Lee, Sun Young, et al.
Publicado: (2021)

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
por: Ngamcherdtrakul, Worapol, et al.
Publicado: (2018)

Cellular Uptake and Antitumor Activity of DOX-hyd-PEG-FA Nanoparticles
por: Ye, Wei-liang, et al.
Publicado: (2014)

The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells
por: Pisani, Cédric, et al.
Publicado: (2017)

Artificial cells eavesdropping on HepG2 cells
por: Westensee, Isabella Nymann, et al.
Publicado: (2023)

Chlorogenic Acid from Burdock Roots Ameliorates Oleic Acid-Induced Steatosis in HepG2 Cells through AMPK/ACC/CPT-1 Pathway
por: Ma, Kaiyang, et al.
Publicado: (2023)

Silica bioreplication preserves three-dimensional spheroid structures of human pluripotent stem cells and HepG2 cells
por: Lou, Yan-Ru, et al.
Publicado: (2015)

Dual stimuli-responsive polyphosphazene-based molecular gates for controlled drug delivery in lung cancer cells
por: Salinas, Yolanda, et al.
Publicado: (2020)

Anti-tumor effect of volatile oil from Houttuynia cordata Thunb. on HepG2 cells and HepG2 tumor-bearing mice
por: Yang, Linsong, et al.
Publicado: (2019)

DNMT1/PKR double knockdowned HepG2 (HepG2-DP) cells have high hepatic function and differentiation ability
por: Tanaka-yachi, Rieko, et al.
Publicado: (2022)

PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction
por: Zheng, Shanyuan, et al.
Publicado: (2012)

Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro
por: Xiang, Guang-Hua, et al.
Publicado: (2013)

Characterization of dengue virus entry into HepG2 cells
por: Suksanpaisan, Lukkana, et al.
Publicado: (2009)

Selectivity of biopolymer membranes using HepG2 cells
por: Lü, Dongyuan, et al.
Publicado: (2015)

Curcumin Effect on Copper Transport in HepG2 Cells
por: Berzina, Anita, et al.
Publicado: (2018)

Cholesterol-lowing effect of taurine in HepG2 cell
por: Guo, Junxia, et al.
Publicado: (2017)

Nevirapine induced mitochondrial dysfunction in HepG2 cells
por: Paemanee, Atchara, et al.
Publicado: (2017)

The Expectation and Reality of the HepG2 Core Metabolic Profile
por: Kiseleva, Olga I., et al.
Publicado: (2023)

Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
por: García-Fernández, Coral, et al.
Publicado: (2020)

Embelin-induced apoptosis of HepG2 human hepatocellular carcinoma cells and blockade of HepG2 cells in the G2/M phase via the mitochondrial pathway
por: TAGHIYEV, ASAF, et al.
Publicado: (2012)

Effect of TAT-DOX-PEG irradiated gold nanoparticles conjugates on human osteosarcoma cells
por: Lupusoru, Raoul V., et al.
Publicado: (2020)

Effect of amino groups of mesoporous silica nanoparticles on CpG oligodexynucleotide delivery
por: Xu, Yi, et al.
Publicado: (2015)

Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury
por: Guo, Xinghua, et al.
Publicado: (2023)

Combination therapy with PEG-IFN-α and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53
por: Hagiwara, S, et al.
Publicado: (2007)

TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
por: Zhu, X, et al.
Publicado: (2016)

Mesoporous silica nanoparticles for drug and gene delivery
por: Zhou, Yixian, et al.
Publicado: (2018)

Mesoporous Silica Nanoparticles for Protein Protection and Delivery
por: Xu, Chun, et al.
Publicado: (2019)

Smart Mesoporous Silica Nanoparticles for Protein Delivery
por: Liu, Hai-Jun, et al.
Publicado: (2019)

Lipid synthesis and secretion in HepG2 cells is not affected by ACTH
por: Skoog, Maria, et al.
Publicado: (2010)

Cadmium Impairs p53 Activity in HepG2 Cells
por: Urani, C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3odjq9tsr0a12oealddgsrkop2